Word count: 2257 Running title: Proteasomes remove N-terminally ubiquitinated tau and α -synuclein oligomers Aggregation of amyloidogenic proteins is an abnormal biological process implicated in neurodegenerative disorders. While the aggregation process of amyloid-forming proteins has been studied extensively, the mechanism of aggregate removal is poorly understood. We recently demonstrated that proteasomes could fragment filamentous aggregates into smaller entities, restricting aggregate size[1]. Here, we show in vitro that UBE2W can modify the N-terminus of both α S and tau K18 with a single ubiquitin moiety. We demonstrate that an engineered N-terminal Ub modification changes the aggregation process of both proteins, resulting in the formation of structurally distinct aggregates. Single-molecule approaches further reveal that the proteasome can target soluble oligomers assembled from Ub-modified proteins independent of its peptidase activity, consistent with our recently reported fibril-fragmenting activity. Based on these results, we propose that proteasomes are able to target oligomers assembled from N-terminally ubiquitinated proteins. Our data suggest a possible disassembly mechanism by which N-terminal ubiquitination and the proteasome may together impede aggregate formation. (151 words)
Introduction
The 26S proteasome holoenzyme is responsible for selective protein degradation in eukaryotic cells [2] . Proteins selected for degradation are often covalently modified with ubiquitin (Ub) moieties, which are recognized by the proteasome [3] . The proteolytic activity required for degradation is provided by the 20S core particle (CP) of the holoenzyme, while the 19S regulatory particle (RP) that caps the CP on one or both ends is responsible for substrate recognition and ATP-dependent substrate unfolding and translocation into the CP [4] [5] [6] . Many biological processes are dependent on the proteasome through controlled degradation of key factors, including homeostasis, unfolded protein response and proteostasis [7] . As such, cellular proteasomes are responsible for degrading damaged proteins, thereby preventing the accumulation of misfolded and amyloidogenic proteins, which have a propensity to form aggregates [8] .
Aggregation of amyloidogenic proteins progresses through several stages, during which protein monomers assemble into soluble aggregates (oligomers) that through further aggregation events eventually undergo conformational rearrangement into filamentous aggregates (fibrils). The process of protein aggregation is harmful to normal cell physiology and is often associated with neurodegenerative disorders [9] .
At the cellular level, accumulation of aggregates could be due to an increased rate of aggregation or decreased rate of aggregate removal, due to e.g. changes in the ability to disassemble or degrade aggregates. Aggregates assembled from amyloidogenic proteins tau and α -synuclein (αS) have been implicated in Alzheimer's (AD) and
Parkinson's disease (PD), respectively [10, 11] . Both tau and α S are intrinsically disordered in their non-amyloid state as monomers, and have been reported to be degradation-resistant as aggregates [12] [13] [14] [15] .
The inability to process certain aggregates may be coincident with proteasome malfunction, which in certain brain regions of AD and PD patients have been reported with decreased activity [16, 17] . We recently demonstrated that the mammalian proteasome holoenzyme possessed a fibril-fragmenting activity, reducing the size of large tau and α S fibrils into smaller entities in vitro [1] . Importantly, the proteasome catalyzed this fibril-fragmenting process in a Ub-independent manner. It is currently unclear how these smaller aggregate entities may be further processed by the cellular mechanisms. A recent study has further detailed the interactions of small soluble aggregated amyloidogenic proteins (oligomers) with the proteasome, which is markedly impaired by oligomer binding [18] .
Studies in cells have indicated that both tau and α S could be degraded by the proteasome in a Ub-dependent manner [19] [20] [21] [22] , suggesting that aggregates of ubiquitinated proteins may accumulate when proteasomal functions are compromised.
This assumption is supported by the observation of abundantly monoubiquitinated tau fibrils isolated from AD patient brain samples [23] . In addition, α S in the PDassociated Lewy Bodies is also mainly monoubiquitinated [17, 24] . Both tau and α S have dedicated Ub ligases, AXOT/MARCH7 [25] and SIAH1 [26, 27] , respectively, which preferentially monoubiquitinate their substrates. UBE2W, a Ub-conjugating enzyme that directly monoubiquitinates the N-terminus of intrinsically disordered proteins [28] , has also been shown to modify tau [22, 23] . Given that proteasomes have affinity for Ub molecules, it is plausible to hypothesize that Ub modification on aggregates would recruit and become targeted by functional proteasomes.
Here we show that the mammalian proteasome holoenzyme can target oligomers assembled from ubiquitinated tau aggregation domain (tau K18 ) and α S. We found that both tau K18 and α S may become ubiquitinated on the N-terminus by UBE2W. Using genetically engineered proteins with an N-terminal Ub moiety on tau K18 and α S, we demonstrated that such Ub modification delayed the aggregation process, which resulted in distinct aggregate structures compared to their unmodified counterparts. In addition, proteasomal functions were maintained in the presence of these Ub-modified aggregates. This was supported by data from single-molecule fluorescence spectroscopy experiments, which found a reduction in the number and the size of oligomers following proteasome treatment. The ability to target oligomers was not affected by Velcade-mediated inhibition of proteasomal proteolytic activity, suggesting that oligomer disassembly is not dependent on degradation. Based on these observations, we propose that N-terminal Ub modification on tau and α S enables proteasomes to target and remove oligomers assembled from these modified proteins.
Results

N-terminal Ub modification on α S and tau K18 delays protein aggregation
We chose to use full-length α S and a tetra-repeat domain of tau (tau K18 ) as model amyloidogenic proteins since both protein constructs have a similar molecular weight (~14 kDa, Figure 1a ). Using established protocols to purify untagged recombinant proteins of wild-type α S and tau K18 , we found that both proteins could be ubiquitinated by UBE2W (Figure 1b) Ub-αS and Ub-tau K18 were allowed to aggregate under identical conditions as their unmodified counterparts and measured by ThT, which bound to β-sheet rich amyloid structures. Unmodified α S entered an exponential phase reaching a halfsaturated ThT intensity (t half ) at ~11 hrs (Figure 1c) . In contrast, the aggregation of Ub-αS showed an extended lag phase, and reached half-saturation with a delay of 14 hrs (t half =25 hrs). This Ub-dependent delay was even more apparent for Ub-tau K18
(estimated t half of 96 hrs), whose aggregation was delayed by ~38 hrs compared to tau K18 (t half =58 hrs, Figure 1d ). These results suggest that Ub modification might decrease the rate of aggregate formation and/or the level of total amyloid aggregates under our reaction conditions.
Aggregates assembled beyond 96 hrs were further imaged under TEM to qualitatively compare the effect of Ub modification. Interestingly, while fibrils were detected from unmodified α S, those formed from Ub-αS mostly appeared as small amorphous assemblies (Figure 2a ). Despite repeated attempts, we could not detect any filamentous aggregates from Ub-αS under TEM. In comparison, Ub-modified tau K18 assembled into aggregates that appeared thinner and less filamentous-like than unmodified tau K18 , which were detected abundantly (Figure 2b) . These results indicate that the morphology of filamentous aggregates is affected by Ub modification.
Single-molecule measurements of Ub-modified aggregates
We previously established single-molecule fluorescence methods to measure the aggregation process independently of aggregate structure and to estimate the proportion of soluble aggregates (oligomers) [29] [30] [31] . In this study, we applied the same method and labeling strategy to attach fluorescent dyes to α S and tau K18 (SFigure 2a). Using this approach, we mixed the same protein labeled with Alexa488 or Alexa647 in a 1:1 molar ratio and initiated the aggregation reaction. Aggregate samples were flowed through a microfluidic channel and excited at suitable wavelengths with two overlapping lasers using a confocal microscope (SFigure 2b).
Oligomers (here defined as 2-150mers) formed during aggregation will contain both dyes and give rise to coincident fluorescent bursts when they pass through the confocal volume of the laser (Two Color Coincidence Detection (TCCD)) [31] , while any monomer signal will not give rise to coincident fluorescent bursts (Figure 3a) .
The fraction of all fluorescence bursts that are coincident is proportional to the fraction of oligomers present and is measured by the association quotient Q (see
Materials and Methods).
We could reproducibly detect oligomers from both tau K18 and Ub-tau K18 early in the aggregation process (Figure 3b ). Oligomers assembled from tau K18 reached an estimated peak level between ~1-3 hrs after reaction initiation. This observation is qualitatively consistent with our previously published results [30] . For Ub-tau K18 the highest oligomer level was detected between ~24-48 hrs of incubation. An apparent reduction of the fraction of oligomers in solution with time was detected in both unmodified and Ub-modified tau K18 . The loss of soluble aggregates as aggregation progresses had previously also been observed for tau K18 without Ub modification [30] , and could be due to presence of aggregates that are either insoluble or too large to enter the microfluidic channel and hence not detected in our single-molecule experiments.
A steady state population of soluble oligomers appeared in the aggregation of both unmodified and Ub-modified α S and did not change appreciably as the reaction proceeded over longer incubation times (Figure 3c) . Only a fraction of the aggregates is therefore able to form ThT-active aggregate species, where the formation of Ubmodified α S aggregates is delayed compared to unmodified α S (shown in Figure 1c ).
The ThT assays further suggest that there could be more β -sheet content in the aggregates formed from unmodified α S, as a bulky Ub moiety in Ub-αS may obstruct close packing.
Proteasomes are able to target Ub-modified aggregates
To study the degradation of Ub-modified amyloidogenic proteins, we purified proteasome holoenzyme from an established mammalian cell line [32] It has been reported that non-ubiquitinated aggregates resist degradation [12] [13] [14] [15] , and that tau and α S oligomers have recently been shown to impede proteasome activity [18] . In addition, we recently demonstrated that the product of proteasome-catalyzed fragmenting of tau and α S fibrils was small aggregate entities, supporting our previous report that proteasomes had no effect on soluble α S oligomers without ubiquitin modification [39] . We therefore tested whether N-terminal Ub modification on tau and α S oligomers would enable their disassembly by proteasomes. ThT was found to bind to the proteasome, which interfered with fluorescence measurements (SFigure 4c). Turning to single-molecule TCCD approach, we reproducibly detected a decrease in the level of soluble oligomers in both Ub-tau K18 and Ub-αS as late as 96 hrs into the aggregation reaction (a typical set of experimental data is shown in Figure 3d and e). Ub-tau K18 oligomers generated throughout the assembly process were largely removed after incubation in the presence of proteasomes (Figure 3d) .
The effect was also significant for oligomers assembled from Ub-αS, which decreased in the presence of the proteasome (Figure 3e ).
We previously used the relative fluorescence intensities of aggregates compared to monomers to calculate the apparent size of aggregates [29] . Analyzing the data in Figure 3c and d revealed that the proteasome caused a general decrease in the aggregate level independently of the apparent aggregate size (STable 1), suggestive of gradual aggregation disassembly and reduction.
Our previous work using the same confocal single-molecule technique found that the proteasome did not target oligomers that are not modified with Ub [12] and that these oligomers are not affected by active chaperones [33] . We therefore attribute the observed reduction in aggregate level specifically to the proteasome. No change in the proteasomal proteolytic or the ATP-dependent activity after incubation with Ubmodified oligomers was observed (Figure 4a and b) , consistent with observations after incubating proteasomes with fibrils [1] .
The fibril-fragmenting activity of proteasome was shown to be independent of the peptidase activity [1] . To test whether the disassembly of Ub-modified aggregates also did not rely on the proteasomal peptidase activity, we repeated the singlemolecule experiments using proteasomes that were pre-incubated with Velcade as before. The decrease in Ub-tau K18 or Ub-αS aggregates was not affected by Velcademediated inhibition (Figure 4c and d) , consistent with our recent observation [1] .
The ability of proteasomes to target Ub-modified oligomers was further resolved by Western blotting. Aggregates assembled from both Ub-tau K18 and Ub-αS were prone to proteasomal activity (SFigure 5a and c), while aggregates assembled from unmodified tau K18 and α S showed no detectable intensity change in the presence or absence of proteasome treatment (SFigure 5b and d). This is consistent with the hypothesis that aggregates formed from proteins N-terminally modified with Ub can be targeted by the proteasome while unmodified aggregates remain unchanged.
Discussion
Our current work has showed that the presence of an N-terminal Ub moiety on tau K18 and α S results in distinct aggregation kinetics and aggregate conformations. The oligomers assembled from these Ub-modified proteins are also prone to proteasomal activity, leading to reduction in their levels. We previously demonstrated that proteasomes are able to target fibrils, as they are structurally distinct from nonfilamentous aggregates [1] . This present study further complements our previous results with an additional proteasomal ability to target Ub-modified oligomers.
As tight assembly and packing are key features of amyloid aggregates, presence of a Ub moiety at the N-terminus could potentially induce soluble oligomers into a conformation distinct from unmodified protein aggregates. In another of our previous work, we found that arachidonic acid could induce a conformational change in soluble α S oligomers that could subsequently be targeted by the proteasome [12] , suggesting that the proteasome acted more effectively on modified than unmodified oligomers, which contained more compact structures.
In addition to restricting or delaying the formation of proteasome-resistant aggregate conformations, it is plausible that the presence of Ub moieties would provide affinity for proteasomes to engage oligomers more faithfully. Avid recognition of dispersed Ub moieties on aggregates may contribute to preferential recognition followed by disassembly of Ub-modified over unmodified aggregates.
Multiple Ub ligases have been proposed to monoubiquitinate amyloidogenic proteins, including UBE2W-mediated N-terminal modification [28, 34] , which may serve as a mechanism to counteract protein aggregation and associated cell damage. Our current study provides a possible option for how oligomers may become disassembled by the mechanisms of the ubiquitin-proteasome system.
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Material and Methods
Molecular biology of plasmids for protein expression
A single Ub moiety was expressed in tandem to the proteins of interest (tau K18 Cys mutations were introduced using site-directed mutagenesis on Ala90 of α S or Ile202 of tau (annotation based on the 0N4R isoform sequence). We previously showed that introduction of Cys and subsequent dye-labeling did not disrupt the integrity and aggregation properties of these proteins [29, 30] . Equivalent mutations were separately introduced into Ub-αS and Ub-tau K18 constructs. The two other Cys residues in wild-type tau K18 sequence were mutated to Ala [30] . Preparation of the supernatant from purification of untagged α S and tau K18 followed established protocols (e.g. [29, 35] ). In brief, the cleared supernatant was poured into a 50 ml falcon tube and incubated in boiling water for 10 min before cooling down to room temperature. The solution was cleared with a second centrifugation step at 21000 × g for 30 min at 4°C and the supernatant filtered before further purification. 
Purification of mammalian proteasomes
Proteasomes were purified from a HEK293T cell line stably expressing a Rpn11-TEV-Biotin tag (kind gift of Lan Huang, UC Irvine) using established protocols [32] .
Briefly, cells were grown to 100% confluence and collected with a scraper before resuspension in ice-cold Proteasome Buffer (50 mM Tris [pH 7.5], 0.5% NP-40, 10% glycerol, 5 mM ATP, 1 mM DTT, 5 mM MgCl 2 ,). A Dounce homogenizer was then used to lyse the cells and the lysate was cleared by centrifugation at 3000 × g for 5 min at 4°C. The lysate was incubated overnight at 4°C in 2-ml bed volume of preequilibrated NeutrAvidin resin beads (Pierce). Unbound proteins were washed off with Proteasome Buffer. Proteasome was subsequently cleaved on the column with TEV protease (Invitrogen) at 30°C and concentrated to > 2 µM before flash-freezing.
UBE2W ubiquitination assays
Ubiquitination assays were carried out at 25°C in Ubiquitination Buffer (50 mM Tris (Figure 1b) .
Protein aggregation assays
For protein aggregation, Ub-tau K18 or tau K18 were diluted in PBS Buffer (MP Biomedicals) containing 0.01% sodium azide to 10 µM final concentration and incubated at 37°C. An equimolar amount of heparin (H3393, Sigma-Aldrich) was added to initiate tau K18 aggregation reactions. Aggregation assays for Ub-αS or α S were performed at 40 µM final protein concentration in PBS Buffer containing 0.01% sodium azide and incubated at 37°C shaking, as described [29] . We did not detect pellets of insoluble fibrils after 10 min centrifugation at 13000 × g for Ub-tau K18 or Ub-αS aggregates.
Thioflavin T fluorescence assays
Thioflavin T (Sigma) was dissolved in PBS and filtered through a 0.02 µm filter. 
where t is the time after aggregation initiation in hrs and Intensity ThT is the mean integral area of fluorescence emission. All plots were calculated and generated using IgorPro (Wavemetrics). The sigmoidal behavior of aggregation produces the time, t half , needed for Intensity ThT to reach 50% of the maximal plateau value.
Degradation assays
Degradation assays were typically performed at 25°C in Degradation Buffer (50 mM 
Resolving of aggregate samples by gel electrophoresis and Western blotting
Proteasomes used in the overnight degradation assays were resolved on self-poured 3% polyacrylamide native gels and detected with a fluorogenic model substrate, LLVY-AMC, as described previously [36] . For Western blotting, protein samples were first separated on 4-12% NuPAGE gels (Invitrogen) and then transferred to PVDF membranes as per manufacturer's protocol (Mini Trans-Blot wet transfer, Biorad). Samples taken were quenched with Lammeli buffer but not heated (to preserve the oligomeric bands). Mouse anti-tau (1E1/A6, Merck) or rabbit anti-αS (ab138501, Abcam) were used as primary antibodies following standard Western blotting methods. Secondary anti-mouse and anti-rabbit antibodies compatible with detection on an Odyssey CLx Imager or a Typhoon scanner were purchased from Li-Cor or Invitrogen.
Colorimetric phosphate assay
ATPase kit containing malachite green and ammonium molybdate was purchased from Abcam (ab65622). For assays in Figure 4b , 40 µl of each reaction (set up as described in the section Degradation assays) was mixed with 6 µl of the malachite green reagent and incubated for 15 min before measurement. The colorimetric output was measured at OD = 650 nm on a microplate reader. A linear standard curve from 0 to 20 mM of free phosphates was established to convert colorimetric reading into phosphate concentration. Three independent replicate experiments were performed for each reaction.
Transmission electron microscopy imaging
Samples shown in Figure 2 were aggregated beyond 96 hrs and applied onto a carbon-coated 400 mesh copper grid (Agar Scientific). Mammalian proteasome was applied at 100 nM concentration. The grids were then washed with double distilled water and stained with 2% (w/v) uranyl acetate for 1 min. TEM images were acquired using Tecnai G2 microscope (13218, EDAX, AMETEK) operating at an excitation voltage of 200 kV.
Single-molecule measurements
The instrument setup and collection of single-molecule data are based on our earlier works and have been extensively described (e.g. refs [29, 37] ). Briefly, singlemolecule data were collected on a custom-built system using overlapping lasers with excitation maxima at 485 nm and 640 nm (see SFigure 2a). The rate of modulation for both lasers was at 10 modulations per millisecond. Samples were measured under flow using custom-made PDMS microfluidics devices following published procedures [38] . Aggregates were assembled from protein monomers labeled with either AlexaFluor 488 or AlexaFluor 647 and mixed in a 1:1 molar ratio for aggregation (SFigure 2a). This ensures that only aggregates will carry both dyes and will be detected by the coincidence criterion [31] .
Degradation assays were performed for 3 hrs (Ub-tau K18 ) or 12 hrs (Ub-αS) and diluted for immediate single-molecule measurement. Fluorescent protein samples were diluted to 100 pM (Ub-αS) or 40 pM (Ub-tau K18 ) final concentration and measured under flow according to previously established methods [30, 38, 39] . The bin time and flow rates for Ub-αS and Ub-tau K18 constructs were individually optimized to achieve the highest value of Q as described previously [12, 30, 38] . Ub-αS aggregates were measured at 100 µl/hr flow rate and the fluorescence signals were collected with 0. measurements is shown in Figure 3d and e.
Single-molecule data analysis
We used the AND criterion to detect coincidence events in the two channels [31] . This separates aggregation events from background monomers by accepting only those signals for which the blue-and the red-excited channels are above the threshold value.
The proportion of monomers that are associated to form oligomers is expressed using the association quotient Q, which is defined as
where A and B are the rates of detection of events in the two fluorescent channels, respectively, and C is the detection rate of coincident events; τ is the interval time of detection so that the ABτ expresses the coincident events that occur by chance [31] .
We also measured the level of background detection of the buffer containing no 647 at the 5' end of each of the single DNA strands, repeatedly gave a Q value of 30%, using the same analysis [37] .
Each single-molecule measurement was normalized to a standard number of frames and the number of significant coincident events was counted. The percentage decrease in oligomers upon proteasome treatment is calculated as follows:
expressed in percentage. The estimation of apparent aggregate size was carried out as previously described [29] . In brief, the approximate monomer number per aggregate can be extracted assuming that 50% of monomers are donor using the equation Table 1 Size dependency of Ub-tau K18 
